Canada | Publication | April 28, 2020 - 5 PM ET
As we previously advised, most deadlines in the period beginning March 16 and ending April 30, 2020, were extended to the next working day.
On April 27, the Canadian Intellectual Property Office (CIPO) extended this period until May 19, 2020.
Interestingly, on April 24 CIPO provided its current operational status in view of the ongoing COVID-19 pandemic and the deadline extension in a viewable presentation.
While CIPO remains open, there are many restrictions on activities conducted in person. Regional offices remain closed. However mail may be dropped off at offices in Gatineau and Ottawa.
The CIPO presentation also included a number of frequently asked questions (FAQs).
One interesting FAQ relates to electronic signatures. CIPO will follow the guidelines provided under section 3.3 of Annex F of the PCT Administrative Instructions.
CIPO will accept the following types of signatures:
Publication
While country risk cannot be avoided in cross-border transactions entirely, it can be effectively mitigated through careful transaction structuring and tailored contractual protections.
Publication
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023
